Jun 03, 2020
American Regent Introduces Estradiol Valerate Injection, USP­; AO Rated and Therapeutically Equivalent to Delestrogen®1, 2
May 29, 2020
Sumitovant Biopharma Announces Myovant Sciences' Additional Positive Efficacy and Cardiovascular Safety Data from Phase 3 HERO Study of Once-Daily, Oral Relugolix in Advanced Prostate Cancer and Publication in the New England Journal of Medicine
May 19, 2020
Hormone Replacement Therapy Market Size Worth $39.6 Billion By 2027: Grand View Research, Inc.
May 15, 2020
Studies Highlight Key Relationships Between Lifestyle, Sexual Health
May 15, 2020
Lipocine Announces Presentations on TLANDO(TM) at AUA Virtual Experience 2020
May 13, 2020
Treatment Potential of LPCN 1144 Demonstrated in a Pre-Clinical NASH and Hepatic Fibrosis Model
Apr 07, 2020
Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product, By Route Of Administration, By Type Of Disease, By Region And Segment Forecasts, 2020 - 2027
Mar 16, 2020
Global Transdermal Drug Delivery Study, 2018-2028: Technologies, Therapeutics, Markets and Companies
Jan 17, 2020
Global Transdermal Patch Industry Outlook and Forecast 2020-2026: Dosage & Price Insights, Clinical Trials by Company, Drug Class, Indication & Patent Information
Jan 07, 2020
Coming Soon: A Menopausal Solution That's Not All About Sex
Dec 09, 2019
BioTE Medical Founder and Chairman Warns of Potential Serious Impact on Women's Health from Recent Position Statement on Women's Testosterone Therapy Lasting Generations
Nov 11, 2019
Lipocine Receives Complete Response Letter for TLANDO(TM) from U.S. FDA
Nov 06, 2019
Endoceutics® Receives Health Canada Approval for INTRAROSA®
Oct 18, 2019
Survey Reveals that Menopausal Women Prefer Oral Medication Over Topical Options to Treat Vaginal Dryness
Oct 17, 2019
New Data Demonstrates That NATESTO® Increases Serum Testosterone And Improves Symptoms While Maintaining Normal Semen Parameters In Men With Low Testosterone Through Six Months
Oct 10, 2019
Lipocine to Present at the H.C. Wainwright 3rd Annual NASH Investor Conference
Oct 01, 2019
Lipocine To Present LPCN 1144 Poster Of Distinction At The Liver Meeting® 2019
Sep 30, 2019
First Biopsy Confirmed Nash Patient Dosed In Lipocine LiFT Study Of LPCN 1144
Sep 23, 2019
Lipocine Announces Presentations at the 20th Annual Fall Meeting of the Sexual Medicine Society of North America
Sep 17, 2019
Lipocine to Present at the Ladenburg Thalmann 2019 Healthcare Conference